Editor's Comparative Analysis
When choosing between New England Journal of Medicine and Acta Haematologica Polonica, researchers should consider the trade-off between prestige (Acta Haematologica Polonica leads with an IF of ) and cost-efficiency, as Acta Haematologica Polonica is a Diamond Open Access venue.
New England Journal of Medicine is published in US, while Acta Haematologica Polonica is headquartered in PL. Both titles are verified via the JournalsHub Live Indexing Tracker for 2026.
| Academic Metric | New England Journal of Medicine | Acta Haematologica Polonica |
|---|---|---|
| General Information | ||
| Publisher | New England Journal of Medicine | Via Medica |
| Country of Origin | US | PL |
| Established | 1812 | 2024 |
| Editor-in-Chief | See Website | See Website |
| Scientific Influence | ||
| Current Impact Factor |
23.78
|
N/A |
| Indexing Status |
|
DOAJ
|
| Review Speed (Decision) | Unknown |
117 days
Standard
|
| Acceptance Rate | N/A | N/A |
| Access & Publication Fees | ||
| Open Access Type | Subscription | Full OA |
| APC Fee (Estimated) | Inquire | FREE (Diamond) |
Historical Impact Factor Comparison
About New England Journal of Medicine
New England Journal of Medicine is a prominent academic journal specializing in Clinical Medicine and Medicine. Published by New England Journal of Medicine in US, the journal serves as an essential platform for researchers to share high-quality scholarly work. It is a subscription-based publication identified by ISSN 0028-4793. With a …
View Full ProfileAbout Acta Haematologica Polonica
Acta Haematologica Polonica is a prominent academic journal specializing in Medicine. Published by Via Medica in PL, the journal serves as an essential platform for researchers to share high-quality scholarly work. It is fully Open Access publication identified by ISSN 0001-5814. The journal aims to advance the boundaries of knowledge …
View Full ProfileSearching for: New England Journal of Medicine impact factor, Acta Haematologica Polonica APC fees, journal comparison tool 2026.